Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.
Speakers:
- Bill Newell, Sutro Biopharma
- Dr. Lisa Drakeman, Biotech Entrepreneur
- Sougato Das, PRISM.science
